Ep 6: DVT - The Changing Paradigm
The treatment of venous thrombosis has historically been undertreated and under-recognised. In this episode, Steve Elias, MD meets with Makis Avgerinos (Uni of Pittsburgh, US), Mitchell Silver (Ohio Health, US), John Moriarty (UCLA, US) and Thomas Bernik (Englewood Health, NJ, US) to discuss how deep vein thrombosis (DVT) has become the latest ‘hot topic’ in vascular medicine. Together they unpick how thought processes and available technologies are changing to better treat this disease.
Listen now for the latest episode from the veinPODCAST series. Prefer video? Watch the vodcast video episode here.
Hosted by @DrSteveElias and produced by Radcliffe Vascular. Follow us on social media for the latest updates on the next episode @RadcliffeVASCU today!
In this episode they discuss:
[03.00] The excitement surrounding new DVT technology
[05.00] DVT devices: the history
[06.25] New devices: changing DVT patient management
[07.30] The ATTRACT trial: what did it teach us and what did it change?
[15.00] The art of medicine: treating the grey areas
[27.00] The advances of catheters: a review
[31.00] The use of non-thrombolytic devices: the right algorithm
[35.00] The advantage of IVUS: a review
[36.33] The limitations of anticoagulation
[39.00] Acute DVT management: what’s missing to improve patient care?
Read MoreRead Less
Superficial vein disease is a lifestyle condition and a relatively non-harmful disease that can be treated. More prevalent in females and often linked to lifestyle choices such as smoking and obesity, it is also typically inherited through genetics, therefore it’s a disease that is difficult for physicians to prevent or control.
So, is superficial disease dead or not?
Read More
So, is superficial disease dead or not?
All Episodes
Is 2020 the death of the congress as we know it?
Will a phoenix rise from the ashes and what will future congress sessions look like in the future?
Non-societal representatives, Manjit Gohel (Charing Cross), Jose Almeida (IVC), Antonio Gasparis (Venous Symposium), Nicos Labroupoulos (EVM) and Prof Frank Veith (VEITH), join the discussion today to examine the issues impacting venous meetings in 2020.
Listen to them discuss the impact that COVID-19 has had on society meeting attendance this year and what’s been learnt about hosting meetings as a result. Hear them discuss the pros and cons of virtual meeting attendance and their thoughts around the challenges of postponement and reinvigoration, as they consider what the future might hold for education in 2021/22.
Read More
Will a phoenix rise from the ashes and what will future congress sessions look like in the future?
Non-societal representatives, Manjit Gohel (Charing Cross), Jose Almeida (IVC), Antonio Gasparis (Venous Symposium), Nicos Labroupoulos (EVM) and Prof Frank Veith (VEITH), join the discussion today to examine the issues impacting venous meetings in 2020.
Listen to them discuss the impact that COVID-19 has had on society meeting attendance this year and what’s been learnt about hosting meetings as a result. Hear them discuss the pros and cons of virtual meeting attendance and their thoughts around the challenges of postponement and reinvigoration, as they consider what the future might hold for education in 2021/22.
Superficial vein disease is a lifestyle condition and a relatively non-harmful disease that can be treated. More prevalent in females and often linked to lifestyle choices such as smoking and obesity, it is also typically inherited through genetics, therefore it’s a disease that is difficult for physicians to prevent or control.
So, is superficial disease dead or not?
Read More
So, is superficial disease dead or not?
The treatment of venous thrombosis has historically been undertreated and under-recognised. In this episode, Steve Elias, MD meets with Makis Avgerinos (Uni of Pittsburgh, US), Mitchell Silver (Ohio Health, US), John Moriarty (UCLA, US) and Thomas Bernik (Englewood Health, NJ, US) to discuss how deep vein thrombosis (DVT) has become the latest ‘hot topic’ in vascular medicine. Together they unpick how thought processes and available technologies are changing to better treat this disease.
Read More
Steve Elias, MD meets with an all-American panel: Suman Wasan, Yogendra Kanthi, Raghu Kolluri and Thom Rooke to discuss the importance of the vascular medicine specialist in treating patients with complex disease.
They look at a number of issues surrounding this underrepresented area of expertise, namely the importance of the relationship between the vascular surgeon, vein specialists and vascular medicine and their broad spectrum of specialities.
Read More
They look at a number of issues surrounding this underrepresented area of expertise, namely the importance of the relationship between the vascular surgeon, vein specialists and vascular medicine and their broad spectrum of specialities.
In part two, Steve Elias, MD, continues his discussion with renowned vascular surgeon and organiser of the VEITHsymposium™, Professor Frank Veith.
They discuss a variety of issues including the ethics of money and malpractice and the importance of educating patients on vascular surgery and vascular disease. Listen to Frank’s take on the VEITH Symposium’s success, how he’d like to see it develop in the future and why he feels interventional cardiologists and radiologists are essential for VEITH’s long-term growth.
Read More
They discuss a variety of issues including the ethics of money and malpractice and the importance of educating patients on vascular surgery and vascular disease. Listen to Frank’s take on the VEITH Symposium’s success, how he’d like to see it develop in the future and why he feels interventional cardiologists and radiologists are essential for VEITH’s long-term growth.
In this two-part series Steve Elias, MD talks to renowned vascular surgeon and organiser of the VEITHsymposium™, Professor Frank Veith.
Part-one sees them discuss a variety of topics in the vascular world including the origins and growth of the VEITHsymposium™ (which is now in its 47th year!), the importance of leadership, working with cardiologists and the controversial issues around procedure abuse in medicine.
Read More
Part-one sees them discuss a variety of topics in the vascular world including the origins and growth of the VEITHsymposium™ (which is now in its 47th year!), the importance of leadership, working with cardiologists and the controversial issues around procedure abuse in medicine.
How has education and training for physicians changed in light of the COVID-19 pandemic? Steve Elias, MD, meets with key industry figures from AngioDynamics, Philips, Medtronic as well as event organisers, Radcliffe Group, to gain a different perspective, this time from industry on their response to the recent pandemic.
Read More
In this episode, Steve Elias meets with a panel of expert venous physicians to discuss the immediate and future challenges that COVID-19 has caused on venous and vascular education.
Hear them relate the impact that COVID-19 has had on various interventional procedures and the effect it’s had on the organisation and timing of key educational meetings. Finally, they express their thoughts on the long-term changes on educational paradigms that the post-COVID era may bring such as live meetings, hybrid meetings, eLearning and the use of webinar-based platforms.
Read More
Hear them relate the impact that COVID-19 has had on various interventional procedures and the effect it’s had on the organisation and timing of key educational meetings. Finally, they express their thoughts on the long-term changes on educational paradigms that the post-COVID era may bring such as live meetings, hybrid meetings, eLearning and the use of webinar-based platforms.
The coordinated registry network (CRN) aims to collect and compare data from diverse registries with similar data points, to help physicians address specific questions based on collective real-world data.
Steve Elias meets with Jens Eldruip-Jorgensen (Maine, US), Marlin Schul (Indiana, US) and Nicholas Osbourne (Michigan, US) to find out more about the aims of the Coordinated Research Network and its impact on real-world practice to treat patients with venous disease. Highlights include discussions around the benefits and challenges of registry data, as well as a look at the current data coming out from the CRN and its implications for clinicians.
Submit your questions/feedback to Steve via: podcast@radcliffe-group.com. Hosted by @DrSteveElias. Produced by @RadcliffeVASCU.
Read More
Steve Elias meets with Jens Eldruip-Jorgensen (Maine, US), Marlin Schul (Indiana, US) and Nicholas Osbourne (Michigan, US) to find out more about the aims of the Coordinated Research Network and its impact on real-world practice to treat patients with venous disease. Highlights include discussions around the benefits and challenges of registry data, as well as a look at the current data coming out from the CRN and its implications for clinicians.
Submit your questions/feedback to Steve via: podcast@radcliffe-group.com. Hosted by @DrSteveElias. Produced by @RadcliffeVASCU.
Is 2020 the death of the congress as we know it?
Will a phoenix rise from the ashes and what will future congress sessions look like in the future?
Non-societal representatives, Manjit Gohel (Charing Cross), Jose Almeida (IVC), Antonio Gasparis (Venous Symposium), Nicos Labroupoulos (EVM) and Prof Frank Veith (VEITH), join the discussion today to examine the issues impacting venous meetings in 2020.
Listen to them discuss the impact that COVID-19 has had on society meeting attendance this year and what’s been learnt about hosting meetings as a result. Hear them discuss the pros and cons of virtual meeting attendance and their thoughts around the challenges of postponement and reinvigoration, as they consider what the future might hold for education in 2021/22.
Read More
Will a phoenix rise from the ashes and what will future congress sessions look like in the future?
Non-societal representatives, Manjit Gohel (Charing Cross), Jose Almeida (IVC), Antonio Gasparis (Venous Symposium), Nicos Labroupoulos (EVM) and Prof Frank Veith (VEITH), join the discussion today to examine the issues impacting venous meetings in 2020.
Listen to them discuss the impact that COVID-19 has had on society meeting attendance this year and what’s been learnt about hosting meetings as a result. Hear them discuss the pros and cons of virtual meeting attendance and their thoughts around the challenges of postponement and reinvigoration, as they consider what the future might hold for education in 2021/22.
Superficial vein disease is a lifestyle condition and a relatively non-harmful disease that can be treated. More prevalent in females and often linked to lifestyle choices such as smoking and obesity, it is also typically inherited through genetics, therefore it’s a disease that is difficult for physicians to prevent or control.
So, is superficial disease dead or not?
Read More
So, is superficial disease dead or not?
The treatment of venous thrombosis has historically been undertreated and under-recognised. In this episode, Steve Elias, MD meets with Makis Avgerinos (Uni of Pittsburgh, US), Mitchell Silver (Ohio Health, US), John Moriarty (UCLA, US) and Thomas Bernik (Englewood Health, NJ, US) to discuss how deep vein thrombosis (DVT) has become the latest ‘hot topic’ in vascular medicine. Together they unpick how thought processes and available technologies are changing to better treat this disease.
Read More
Steve Elias, MD meets with an all-American panel: Suman Wasan, Yogendra Kanthi, Raghu Kolluri and Thom Rooke to discuss the importance of the vascular medicine specialist in treating patients with complex disease.
They look at a number of issues surrounding this underrepresented area of expertise, namely the importance of the relationship between the vascular surgeon, vein specialists and vascular medicine and their broad spectrum of specialities.
Read More
They look at a number of issues surrounding this underrepresented area of expertise, namely the importance of the relationship between the vascular surgeon, vein specialists and vascular medicine and their broad spectrum of specialities.
In part two, Steve Elias, MD, continues his discussion with renowned vascular surgeon and organiser of the VEITHsymposium™, Professor Frank Veith.
They discuss a variety of issues including the ethics of money and malpractice and the importance of educating patients on vascular surgery and vascular disease. Listen to Frank’s take on the VEITH Symposium’s success, how he’d like to see it develop in the future and why he feels interventional cardiologists and radiologists are essential for VEITH’s long-term growth.
Read More
They discuss a variety of issues including the ethics of money and malpractice and the importance of educating patients on vascular surgery and vascular disease. Listen to Frank’s take on the VEITH Symposium’s success, how he’d like to see it develop in the future and why he feels interventional cardiologists and radiologists are essential for VEITH’s long-term growth.